Simulations Plus Inc (SLP)

Add to Watchlists
Create an Alert
Quickflows
62.50 +0.14  +0.22% NASDAQ Apr 9, 20:00 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All SLP News

News

View All Events

Events

Date Type Description
04/23/2020 None Dividends 0.06 Normal, declared April 09, 2020 and paid May 01, 2020
07/09/2020 16:15 EDT Earnings Calls Q3 2020 Earnings Call
07/09/2020 00:00 Earnings Results Q3 2020 Earnings Results
07/24/2020 None Dividends 0.06 Normal, declared July 09, 2020 and paid August 03, 2020
10/23/2020 None Dividends 0.06 Normal, declared October 13, 2020 and paid November 02, 2020
11/16/2020 00:00 Earnings Results Q4 2020 Earnings Results
11/16/2020 16:15 EST Earnings Calls Q4 2020 Earnings Call
01/11/2021 00:00 Earnings Results Q1 2021 Earnings Results
01/11/2021 16:15 EST Earnings Calls Q1 2021 Earnings Call
01/22/2021 None Dividends 0.06 Normal, declared January 12, 2021 and paid February 01, 2021
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 42.89M
Total Expenses (TTM) 30.95M
Net Income (TTM) 9.753M

Balance Sheet View Statement

Total Assets (Quarterly) 170.47M
Total Liabilities (Quarterly) 12.44M
Shareholders Equity (Quarterly) 158.03M

Cash Flow Statement View Statement

Cash from Operations (TTM) 13.61M
Cash from Investing (TTM) -100.84M
Cash from Financing (TTM) 102.27M

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.simulations-plus.com
  • Investor Relations URL: https://www.simulations-plus.com/investorscorporate-profile/corporate-profile/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Health Information Services
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Apr. 12, 2021
  • Last Earnings Release: Jan. 11, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Jan. 22, 2021
  • Description: Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Simulations Plus, Inc; Cognigen Corporation; DILIsym, and Lixoft. It generates maximum revenue from Simulations Plus, Inc segment. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) Predictor which is a computer program that takes molecular structures as inputs; MedChem Designer and MedChem Studio.

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 62.50
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
PBSRX Polen US Small Company Growth Investor 3.82%
CSMVX Congress Small Cap Growth Retail 3.10%
RTSGX Transamerica Small Cap Growth R6 2.04%
JSML Janus Henderson Small Cap Gr Alpha ETF 1.24%
SMECX Invesco Small Cap Equity C 1.22%
RMT Royce Micro Cap Trust 1.19%
MSEIX AMG Veritas Asia Pacific I 0.82%
RNSC First Trust Small Cap US Equity Sel ETF 0.76%
RSCRX Russell Inv US Small Cap Equity R6 0.62%

Comparables

Edit
INOV Inovalon Holdings Inc
ONEM 1Life Healthcare Inc
SDGR Schrodinger Inc
VEEV Veeva Systems Inc
VNTH Nano Mobile Healthcare Inc

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.